Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Sponsors
DMM Ayurved Mahavidyalaya,Yavatmal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient diagnosed with lipoma or multiple lipomas. 2. Patient with lipoma size having a diameter is less than 4cm. 3. Sites of lipoma Subcutaneous only. 4. Age group above 18 and below 60 years. 5. Patients willing for clinical trial. Irrespective of gender, occupation, religion, and economic barrier. 6. Patients with controlled DM and Hypertension.
Exclusion criteria
Exclusion criteria: 1.) Sites of lipoma Periosteal, Sub serosal, Submucosal (GI tract), Extradural (not intradural), Intra-articular, Sub- synovial, Sub-periosteal, Intraglandular breast, pancreas, kidney. If a patient develops any adverse effects which cause life-threatening conditions. 2.) Patients with other systemic diseases such as AIDS, HBsAg, TB, Uncontrolled Diabetes, Uncontrolled Hypertension, Malignancy, and Leprosy may affect the outcome of the Treatment. 3.) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The parameters will be noted down before and after treatment. 1.Size of swelling Timepoint: 14 Days study. 3 times per week for 2 weeks. 1st, 3rd, 5th, 7th, 9th, 11. final follow up on 21st day. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) No improvement - 0 % relief in swelling. 2) Poor improvement - 0%-25% relief in swelling. 3) Mild improvement 26% to 50% relief in swelling. 4) Moderate improvement 51% to 75 % relief in swelling. 5) Marked improvement 76% to 100% relief in swelling. Timepoint: 14 Days study. 3 times per week for 2 weeks. 1st, 3rd, 5th, 7th, 9th, 11. Final follow-up on 21st day. | — |
Countries
India
Contacts
Public ContactDr Aditya Thamdeo Fulzele
Dayabhai Maoji Majithiya Ayurved Mahavidyalaya ,Yavatma
Outcome results
None listed